Abstract
A concise asymmetric synthesis of an 11β-HSD-1 inhibitor has been achieved using inexpensive starting materials with excellent step-economy at low catalyst loadings. The catalytic enantioselective total synthesis of 1 was accomplished in 7 steps and 38% overall yield aided by the development of an innovative, sequential strategy involving Pd-catalyzed pyridinium C-H arylation and Ir-catalyzed asymmetric hydrogenation of the resulting fused tricyclic indenopyridinium salt highlighted by the use of a unique P,N-ligand (MeO-BoQPhos) with 1000 ppm of [Ir(COD)Cl]2.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors*
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 / metabolism
-
Catalysis
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Hydrogenation
-
Iridium / chemistry
-
Molecular Conformation
-
Palladium / chemistry
-
Piperidines / chemical synthesis*
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Stereoisomerism
Substances
-
Enzyme Inhibitors
-
Piperidines
-
Iridium
-
Palladium
-
piperidine
-
11-beta-Hydroxysteroid Dehydrogenase Type 1